HemaSphere (Jun 2022)

S159: QUÉBEC CML RESEARCH GROUP ANALYSIS OF TREATMENT PATTERNS IN CHRONIC MYELOGENOUS LEUKEMIA: SWITCHING IS DRIVEN BY INTOLERANCE AND SIMILAR ACROSS TYROSINE KINASE INHIBITORS AND LINES OF TREATMENT

  • L. Busque,
  • M. Harnois,
  • N. Szuber,
  • R. Delage,
  • L. Mollica,
  • H. Olney,
  • P. Laneuville,
  • S. Sirhan,
  • G. Cournoyer,
  • I. Chamakhi,
  • M. Lalancette,
  • D. Talbot,
  • V. Éthier,
  • P. Desjardins,
  • S. Assouline

DOI
https://doi.org/10.1097/01.HS9.0000843528.26169.66
Journal volume & issue
Vol. 6
pp. 60 – 61

Abstract

Read online

No abstracts available.